Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02011295 · ClinicalTrials.gov registry record · NA
Bone Marrow Aspirate Concentrate (BMAC) Supplementation for Osteochondral Lesions
A NA study, sponsored by Duke University.
- Completed
- Registry status
- NA
- Development phase
- 17
- Enrollment target
NCT02011295: Completed NA study, sponsored by Duke University.
NCT02011295 is a NA study that has completed, run by Duke University. The registered enrollment target is 17 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02011295, a NA study, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- NA
- Development phase
- 17 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the clinical efficacy of the application of bone marrow aspirate concentrate (BMAC) as a supplement to microfracture in the treatment of osteochondral lesions of the talus (OLTs).
Primary Outcome
Visual Analog Scale (VAS)
Interventions
- PROCEDURE ankle arthroscopy with debridement and microfracture of the OLT
- OTHER Bone Marrow Aspirate injection
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17 participants |
| Start Date | 2014-01-29 |
| Est. Completion | 2019-06-26 |
| Phase | NA |
What the finished NCT02011295 record still lists
NCT02011295 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 17 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 2 interventions - of which ankle arthroscopy with debridement and microfracture of the OLT is the first listed.
NCT02011295 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02011295 about?
NCT02011295 is a clinical study titled "Bone Marrow Aspirate Concentrate (BMAC) Supplementation for Osteochondral Lesions". The purpose of this study is to determine the clinical efficacy of the application of bone marrow aspirate concentrate (BMAC) as a supplement to microfracture in the treatment of osteochondral lesions of the talus (OLTs).
What is the current status of trial NCT02011295?
This trial is currently completed. It is a NA study. The enrollment target is 17 participants. The study started on 2014-01-29. Estimated completion is 2019-06-26.
What interventions are being tested in trial NCT02011295?
The interventions under investigation include: ankle arthroscopy with debridement and microfracture of the OLT (PROCEDURE), Bone Marrow Aspirate injection (OTHER).
Who is sponsoring clinical trial NCT02011295?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02011295's enrollment target sits among peer trials
17 1871st of 2000 higher than 130 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02090140 · 17 participants · NA
Microfracture Versus Adipose Derived Stem Cells for the Treatment of Articular Cartilage Defects
- NCT03317860 · 17 participants · NA
Improving Measurement and Treatment of Post-stroke Neglect
- NCT04356469 · 17 participants · Phase 2
TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Non-Malignant Hematological Disorders in Children
- NCT04414046 · 17 participants · Phase 2
TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Primary Immunodeficiency and Inherited Metabolic Disorders in Children
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI